Healthcare -
Biotechnology - NASDAQ - US
$ 33.985
-4.38 %
$ 1.95 B
Market Cap
2.92
P/E
AGIO - COST OF REVENUE
Cost of Revenue AGIO - Agios Pharmaceuticals, Inc.
4.16 M
LAST VALUE
56.34%
2 YEAR CAGR
25.89%
5 YEAR CAGR
-27.26%
10 YEAR CAGR